Clinical studies A total of 22 completed clinical studies were identified (Table 1 and Extended Data Tables 1 and 2), with another 8 clinical trials still ongoing (Supplementary Section 3)
According to Table 1, comprehensive experimental and observational studies reveal that GLP-1RAs do not elevate overall cancer risk, while preclinical investigations have demonstrated multiple anti-tumor mechanisms, including proliferation inhibition, apoptosis induction, and metastasis suppression
LiHWangYGuoJZhangPXuZPengKet al
Katie's been injecting GHK-Cu, a copper peptide, for several weeks now and she's confident it's making a difference to her skin
Peptide Injection List To view a comprehensive list of all peptides and their benefits, please click here